Filing Details

Accession Number:
0001213900-25-016122
Form Type:
13D Filing
Publication Date:
2025-02-20 19:00:00
Filed By:
Hatteras Venture Advisors IV SBIC, LLC
Company:
Clearside Biomedical Inc.
Filing Date:
2025-02-21
SEC Url:
13D Filing
Ownership Summary

Please notice the below summary table is generated without human intervention and may contain errors. Please refer to the complete filing displayed below for exact figures.

Name Sole Voting Power Shared Voting Power Sole Dispositive Power Shared Dispositive Power Aggregate Amount Owned Power Percent of Class
Hatteras Venture Advisors IV SBIC, LLC 0 0 0 0 0 0%
Hatteras Venture Partners IV SBIC, LP 0 0 0 0 0 0%
Hatteras Venture Advisors IV, LLC 0 0 0 0 0 0%
Hatteras Venture Partners IV, LP 0 0 0 0 0 0%
Hatteras NC Fund, LP 0 0 0 0 0 0%
John C. Crumpler 125,793 0 125,793 0 125,793 0.2%
Robert A. Ingram 130,881 0 130,881 0 130,881 0.2%
Kenneth B. Lee 86,324 0 86,324 0 86,324 0.1%
Clay B. Thorp 313,641 0 313,641 0 313,641 0.4%
Douglas Reed 127,011 0 127,011 0 127,011 0.2%
Filing





If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box. Checkbox not checked

The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).






SCHEDULE 13D





SCHEDULE 13D





SCHEDULE 13D





SCHEDULE 13D





SCHEDULE 13D





SCHEDULE 13D





SCHEDULE 13D





SCHEDULE 13D





SCHEDULE 13D



Comment for Type of Reporting Person:
Includes 152,500 shares of Common Stock subject to options held by Mr. Thorp that are exercisable within 60 days of February 21, 2025.


SCHEDULE 13D





SCHEDULE 13D

 
Hatteras Venture Advisors IV SBIC, LLC
 
Signature:/s/ Clay B. Thorp
Name/Title:Clay B. Thorp, Manager
Date:02/21/2025
 
Hatteras Venture Partners IV SBIC, LP
 
Signature:/s/ Clay B. Thorp
Name/Title:Clay B. Thorp, Manager
Date:02/21/2025
 
Hatteras Venture Advisors IV, LLC
 
Signature:/s/ Clay B. Thorp
Name/Title:Clay B. Thorp, Manager
Date:02/21/2025
 
Hatteras Venture Partners IV, LP
 
Signature:/s/ Clay B. Thorp
Name/Title:Clay B. Thorp, Manager
Date:02/21/2025
 
Hatteras NC Fund, LP
 
Signature:/s/ Clay B. Thorp
Name/Title:Clay B. Thorp, Manager
Date:02/21/2025
 
John C. Crumpler
 
Signature:/s/ Clay B. Thorp
Name/Title:Clay B. Thorp, by Power of Attorney
Date:02/21/2025
 
Robert A. Ingram
 
Signature:/s/ Clay B. Thorp
Name/Title:Clay B. Thorp, by Power of Attorney
Date:02/21/2025
 
Kenneth B. Lee
 
Signature:/s/ Clay B. Thorp
Name/Title:Clay B. Thorp, by Power of Attorney
Date:02/21/2025
 
Clay B. Thorp
 
Signature:/s/ Clay B. Thorp
Name/Title:Clay B. Thorp
Date:02/21/2025
 
Douglas Reed
 
Signature:/s/ Clay B. Thorp
Name/Title:Clay B. Thorp, by Power of Attorney
Date:02/21/2025
Comments accompanying signature:
This Amendment No. 7 to Schedule 13D was executed by Clay B. Thorp on behalf of the individuals listed above pursuant to a Power of Attorney a copy of which was previously filed with the Reporting Person's Schedule 13D filed with the SEC on June 17, 2016 and as amended on February 8 and April 25, 2017, March 21, 2018, July 17 and December 4, 2019 and January 4, 2023.